Searching in Healthcare · Search everything
756 changes Healthcare
Scientific Literature Reference Rao 2017 FDA-2026-P-3869
A scientific literature reference (Rao 2017) has been submitted to FDA docket FDA-2026-P-3869. The document appears to be supporting scientific literature provided as part of comments or a submission to the FDA regulatory process. No regulatory requirements, deadlines, or penalties are established by this document submission.
Yang 2022 Scientific Literature Reference
A scientific literature reference authored by Yang (2022) was submitted to FDA docket FDA-2026-P-3869 as supporting documentation. The document was filed on April 3, 2025, and is accessible via regulations.gov. This appears to be part of a food additive petition or similar regulatory submission process requiring scientific literature support.
Scientific Reference Costenbader 2007, FDA-2026-P-3869
FDA has published a scientific reference document (Costenbader 2007) as part of docket FDA-2026-P-3869. The document was submitted as supporting scientific literature for a Pre-Market Notification submission. The actual content is restricted due to copyright and cannot be displayed.
Sanchez-Guerrero 1997 Scientific Literature Reference
FDA has received and filed a scientific literature reference (Sanchez-Guerrero 1997) in regulatory docket FDA-2026-P-3869. The document has been uploaded to the public docket and is accessible to interested parties. The content of the reference cannot be displayed due to copyright restrictions.
Scientific Literature Reference - Content Restricted
FDA received a submission on regulations.gov containing a scientific literature reference that is restricted due to copyright limitations. The specific content of the referenced literature is not accessible. The submission appears in FDA's docket system but the substantive regulatory material cannot be reviewed.
FDA Complaint FDA-2026-H-3943-0001
FDA received a complaint under docket FDA-2026-H-3943-0001 on April 15, 2025. The Center for Tobacco Products authored the complaint. The public comment period for this docket is now closed. No documents are available for viewing or download from the regulatory docket.
Citizen Petition to FDA by Kaylin Bower
A citizen petition was filed with the FDA's Center for Drug Evaluation and Research (CDER) by Kaylin Bower on April 15, 2026. The petition docket is FDA-2026-P-4104-0001. The full contents of the petition are redacted due to personally identifiable information protections, limiting visibility into the specific regulatory relief requested.
Scientific Literature Reference Copyright Restricted
FDA published a document on regulations.gov (FDA-2026-P-3869-0004) regarding scientific literature references. The submission contains copyright-restricted content and is not fully accessible to the public. The document appears to be a regulatory submission or comment filed with FDA.
Manhart 2013 Scientific Literature Submission FDA-2026-P-3869
FDA has received a docket submission to FDA-2026-P-3869 containing a citation to Manhart 2013 scientific literature. The full content of the submission is restricted due to copyright and is not publicly viewable in the docket.
Narula 2022 IBD Scientific Literature, FDA-2026-P-3869
Narula 2022 IBD Scientific Literature, FDA-2026-P-3869